Kuopio University Hospital   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Kuopio Finland (1973)

Organization Overview

First Clinical Trial
1996
NCT00877097
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Department of Anesthesiology and Intensive Care, Kuopio University hospital, Kuopio, Finland | Department of Intensive Care, Kuopio UH | Dept. of Obstetrics and Gynecology, Kuopio University Hospital | Kuopio University Central Hospital | Kuopio University Hospital | Kuopio University Hospital, Department of Ophthalmology | Kuopio University Hospital, Finland | Kuopio University Hospital, Kuopio, FI | Kuopio University Hospital, Kuopio, Finland | Kuopio University Hospital, University of Eastern Finland

Active Ingredients

Drugs in Phase 4 Trials (23)

amiodarone (cordarone) (1 trial)

buprenorphine (1 trial)

calcium (1 trial)

collagenase clostridium histolyticum (xiaflex) (1 trial)

dexibuprofen (1 trial)

escherichia coli nissle 1917 (1 trial)

etoricoxib (Gencox) (1 trial)

fentanyl (Innovar) (1 trial)

hydroxychloroquine (plaquenil) (1 trial)

imatinib (gleevec) (1 trial)

infliximab (remicade) (2 trials)

levobupivacaine (chirocaine) (1 trial)

levosimendan (2 trials)

metoprolol (lopressor) (3 trials)

naloxone (narcan) (3 trials)

naltrexone (revia) (2 trials)

oxycodone (oxycontin) (7 trials)

prednisone (meticorten) (1 trial)

remdesivir (Veklury) (1 trial)

remifentanil (ultiva) (1 trial)

ropivacaine (naropin) (1 trial)

sulfasalazine (azulfidine) (2 trials)

vitamin d3 (2 trials)

Drugs in Phase 3 Trials (12)

adalimumab (humira) (1 trial)

atorvastatin (lipitor) (1 trial)

bortezomib (velcade) (1 trial)

dexmedetomidine (precedex) (2 trials)

hydrocortisone (solu-cortef) (1 trial)

letrozole (femara) (1 trial)

propofol (diprivan) (1 trial)

quetiapine (seroquel) (1 trial)

risperidone (risperdal) (1 trial)

sodium chloride (3 trials)

testosterone (delatestryl) (1 trial)

urea (3 trials)

Drugs in Phase 2 Trials (11)

advvegf-d (1 trial)

anakinra (Kineret) (1 trial)

azathioprine (imuran) (1 trial)

cabazitaxel (jevtana kit) (1 trial)

celecoxib (celebrex) (1 trial)

cyclophosphamide (cytoxan) (1 trial)

etoposide (vepesid) (1 trial)

leflunomide (arava) (1 trial)

sargramostim (leukine) (1 trial)

thalidomide (Thalomid) (1 trial)

venetoclax (venclexta) (1 trial)

Drugs in Phase 1 Trials (2)

cis-urocanic acid (1 trial)

vegf-d gene transfer (1 trial)

Drugs in Other Trials (20)

acetylsalicylic acid (aspirin) (1 trial)

azithromycin (zithromax) (1 trial)

benzocaine (Orajel) (1 trial)

budesonide (rhinocort) (1 trial)

cefuroxime (zinacef) (1 trial)

clodronate (1 trial)

ertapenem (invanz) (3 trials)

estradiol (progynon depot) (1 trial)

ethinyl estradiol (Estinyl) (1 trial)

human fecal microbiota (Reybota) (1 trial)

levofloxacin (levaquin) (1 trial)

methadone (methadose) (1 trial)

metronidazole (flagyl) (1 trial)

moxifloxacin (avelox) (2 trials)

norethindrone (1 trial)

rituximab (rituxan) (1 trial)

rivastigmine (exelon) (1 trial)

tacrolimus (prograf) (1 trial)

triamcinolone (kenalog) (1 trial)

whole wheat allergenic extract (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Angina Pectoris (Phase 2)

Arthritis (Phase 4)

Arthritis, Juvenile (Phase 2)

Arthritis, Rheumatoid (Phase 4)

Atrial Fibrillation (Phase 4)

Breast Neoplasms (Phase 3)

Communicable Diseases (Phase 4)

Constipation (Phase 4)

Contracture (Phase 4)

Coronary Artery Disease (Phase 2)

Coronary Disease (Phase 1)

Dupuytren Contracture (Phase 4)

Fractures, Bone (Phase 4)

Heart Diseases (Phase 1)

Heart Failure (Phase 4)

Heart Valve Diseases (Phase 4)

Infarction (Phase 1)

Infections (Phase 4)

Intervertebral Disc Displacement (Phase 3)

Intestinal Diseases (Phase 4)

Labor Pain (Phase 4)

Mastodynia (Phase 3)

Multiple Myeloma (Phase 3)

Myocardial Infarction (Phase 1)

Myocardial Ischemia (Phase 1)

Neoplasms, Plasma Cell (Phase 2)

Osteoarthritis (Phase 4)

Osteoporosis (Phase 4)

Pain, Postoperative (Phase 4)

Prolapse (Phase 3)

Prostatic Neoplasms (Phase 3)

Schizophrenia (Phase 3)

Still's Disease, Adult-Onset (Phase 2)

Urinary Tract Infections (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 56
  • # of Trial APIs: 68